WHO approval of Chinese vaccine will accelerate Covax supply: analysts


BEIJING (Global Times): The WHO's emergency approval of China's Covid-19 vaccine will boost global vaccine supply amid shortfall as China's overall yearly production capacity is approaching five billion doses, observers said.

The WHO gave Emergency Use Listing (EUL) to Sinopharm's Covid-19 vaccine on Friday (May 7) afternoon, making it the sixth vaccine and the first made by a non-Western country to receive WHO validation for its safety, efficacy and quality.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

China , Covax , vaccine , supply , WHO , approval

   

Next In Aseanplus News

Corrupt individuals who fail to pay penalties for bribes received may face longer jail terms: Court of Appeal in Singapore
Myanmar marks International Day of Persons with Disabilities through sports events
Thai police crack down on shell companies linked to cybercrime in networks
13 missing after south China railway construction site collapse
Analysis: Prabowo opens Pandora’s box on Indonesia’s capital punishment
Mekong leaders warn climate change ‘driving hotspots, haze’
Lao PM set to boost ties with Cambodia through official visit
First man to receive liver transplant in Vietnam still healthy after 14 years
FashionValet founders plead not guilty to RM8mil CBT charge
Mild earthquake hits Tawau

Others Also Read